The ethics of global clinical trials In developing countries, participation in clinical trials is sometimes the only way to access medical treatment. What should be done to avoid exploitation of disadvantaged populations?

被引：53

作者：

Weigmann, Katrin

机构：

来源：

关键词：

D O I：

10.15252/embr.201540398

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：566 / 570

页数：5

共 4 条

[1]

[Anonymous], 2009, EXPT TRAVEL CLIN TRI

Glickman, Seth W. ;

McHutchison, John G. ;

Peterson, Eric D. ;

Cairns, Charles B. ;

Harrington, Robert A. ;

Califf, Robert M. ;

Schulman, Kevin A. .

[3]

Schulz-Baldes A, 2007, EMBO REP, V8, P8, DOI 10.1038/sj.embor.7400886

Wolinsky, Howard .